Arild Nesbakken

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 77 publications

Temporal Trends in Cancer Mortality Among People Younger Than 50 Years in Norway.

Temporal Trends in Cancer Mortality Among People Younger Than 50 Years in Norway.

Journal: JAMA network open

Published: August 14, 2026

Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivity.

Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivity.

Journal: Cell reports. Medicine

Published: December 11, 2025

Generalisation of automatic tumour segmentation in histopathological whole-slide images across multiple cancer types.

Generalisation of automatic tumour segmentation in histopathological whole-slide images across multiple cancer types.

Journal: NPJ precision oncology

Published: October 29, 2025

Bisacodyl micro-enema before MRI of rectal tumors: effects on rectum, image quality and patient acceptance.

Bisacodyl micro-enema before MRI of rectal tumors: effects on rectum, image quality and patient acceptance.

Journal: European radiology

Published: May 20, 2025

MRI of early rectal cancer; bisacodyl micro-enema increases submucosal width, reader confidence, and tumor conspicuity.

MRI of early rectal cancer; bisacodyl micro-enema increases submucosal width, reader confidence, and tumor conspicuity.

Journal: Abdominal radiology (New York)

Published: September 25, 2024

Early rectal cancer: The diagnostic performance of MRI supplemented with a rectal micro-enema and a modified staging system to identify tumors eligible for local excision.

Early rectal cancer: The diagnostic performance of MRI supplemented with a rectal micro-enema and a modified staging system to identify tumors eligible for local excision.

Journal: Acta radiologica open

Published: March 08, 2024

The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration.

The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: February 12, 2024

Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancer.

Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancer.

Journal: Nature communications

Published: August 23, 2023

Hospital use and cancer treatment by age and socioeconomic status in the last year of life: A Norwegian population-based study of patients dying of cancer.

Hospital use and cancer treatment by age and socioeconomic status in the last year of life: A Norwegian population-based study of patients dying of cancer.

Journal: Journal of geriatric oncology

Published: December 12, 2022

A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study.

A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study.

Journal: The Lancet. Oncology

Published: March 31, 2022

Spatial analysis and CD25-expression identify regulatory T cells as predictors of a poor prognosis in colorectal cancer.

Spatial analysis and CD25-expression identify regulatory T cells as predictors of a poor prognosis in colorectal cancer.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: February 17, 2022

E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models.

E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models.

Journal: Molecular oncology

Published: August 17, 2021

Showing 1-12 of 77

Last Updated: 09/26/2026